Top 10 Clinical Trends for January 2015

Ryan Syrek


January 27, 2015

#8 Clinical Trend: Contrave

Sales of Orexigen's Contrave, an antiobesity drug, have escalated quickly. Whereas a similar drug, Belviq, took 37 weeks to get over the 6,000 script mark, Contrave achieved that total in 9 weeks. Clearly, the booming popularity led health care providers to find out what all the fuss is about.

For more in-depth clinical information, see Obesity.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.